Survival of chronic myeloid leukaemia patients treated by dibromomannitol.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000477:Alkylating Agents / Q000627:therapeutic use*; D001966:Bromine / Q000627:therapeutic use; D002066:Busulfan / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008353:Mannitol / Q000627:therapeutic use*; D008875:Middle Aged; D012189:Retrospective Studies; D013997:Time Factors
D000477:Alkylating Agents; D008353:Mannitol; D002066:Busulfan; D001966:Bromine